SCHEMBL16691276

SCHEMBL16691276

Cc1ccccc1N1CCOc2cnc(Cl)nc21

nearest known ligand 0.55

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ PSEN1 P49768 9/20 0.55
▸ PSEN2 P49810 9/20 0.55
▸ APH1B Q8WW43 9/20 0.55
▸ NCSTN Q92542 9/20 0.55
▸ APH1A Q96BI3 9/20 0.55
▸ PSENEN Q9NZ42 9/20 0.55
▸ MAPT P10636 1/20 0.36
▸ CYP17A1 P05093 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ NUDT1 P36639 1/20 0.34
▸ HCRTR2 O43614 1/20 0.34
▸ RPS6KA5 O75582 1/20 0.34
▸ GRM1 Q13255 1/20 0.34
▸ DDB1 Q16531 1/20 0.33
▸ CRBN Q96SW2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16691277 0.87 PSEN1 (0.49) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL16691273 0.81 PSEN1 (0.53) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL16691291 0.79 PSEN1 (0.53) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL16691347 0.77 SCN9A (0.40) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL16691344 0.76 PSEN1 (0.49) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL16691282 0.76 PSEN1 (0.48) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL16691348 0.75 PSEN1 (0.42) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL30749107 0.74 PSEN1 (0.45) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL16686167 0.74 PSEN1 (0.50) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL16691349 0.74 PSEN1 (0.47) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015066697-A1 FUSED MORPHOLINOPYRIMIDINES AND METHODS OF USE THEREOF FORUM PHARMACEUTICALS INC. (US) 2015-05-07 — — WO disclosed
WO-2015066696-A1 FUSED MORPHLINOPYRIMIDINES AND METHODS OF USE THEREOF FORUM PHARMACEUTICALS INC. (US) 2015-05-07 — — WO disclosed
Send feedback